Contemporary Clinical Practices in Korean Patients With Coronary Chronic Total Occlusion: Results From the K-CTO

Jung-Joon Cha1, Yonggu Lee2, Dong-Eon Kim3

  • 1Department of Cardiology, Cardiovascular Center, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea.

Insights

This study of coronary chronic total occlusion (CTO) in South Korea found that most patients underwent percutaneous coronary intervention (PCI) with high success rates. Further adoption of advanced techniques may improve outcomes for complex CTO cases.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Public Health

Background:

  • Coronary chronic total occlusion (CTO) presents significant challenges in cardiovascular disease management.
  • Limited large-scale real-world data exist on contemporary CTO clinical practice and outcomes.

Purpose of the Study:

  • To describe current clinical practices for CTO in South Korea.
  • To analyze outcomes of percutaneous coronary intervention (PCI) for CTO patients.

Main Methods:

  • Utilized the nationwide retrospective Korean Chronic Total Occlusion (K-CTO) registry 2.0.
  • Analyzed data from 9,316 patients diagnosed with CTO between 2003 and 2023 across 34 centers.
  • Included demographic, clinical, procedural, and outcome data, irrespective of PCI performance.

Main Results:

  • 7,267 (78.0%) patients underwent PCI with an overall procedural success rate of 82.2%.
  • Antegrade and retrograde approaches showed success rates of 82.8% and 78.5%, respectively.
  • Five-year cumulative incidences for major adverse cardiac and cerebrovascular events and all-cause mortality were 30.4% and 14.5%, respectively.

Conclusions:

  • Most CTO patients in South Korea receive PCI with high procedural success.
  • Findings highlight the need for broader adoption of advanced techniques and devices for complex CTO lesions.
  • These descriptive results do not confirm improved long-term outcomes but provide a benchmark for current practice.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...